Effect of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) on Lipid Particles in Type 2 Diabetes Mellitus (T2DM)

被引：0
|
作者：
Jones, Michael R.
Ford, Daniel M.
Baz-Hecht, Merav
Tao, Ben
Truitt, Kenneth E.
Chou, Hubert S.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1161-P
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [31] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [32] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [33] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [34] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    [J]. FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [35] The Role of Colesevelam HCl in Type 2 Diabetes Mellitus Therapy
    Handelsman, Yehuda
    [J]. POSTGRADUATE MEDICINE, 2009, : 19 - 24
  • [36] Progression of microalbuminuria during a long-term open-label (OL) trial of pioglitazone (PIO) in patients with type 2 diabetes mellitus (T2DM)
    Perez, A
    Cichy, S
    Glazer, B
    [J]. DIABETES, 2002, 51 : A111 - A111
  • [37] Independent Increases in Insulin Sensitivity and Adipocyte GIP-R Expression Following Pioglitazone (PIO) Treatment in Patients With Type 2 Diabetes Mellitus (T2DM)
    Tharp, William G.
    Sideleva, Olga
    Maple, Rhonda L.
    Ferro, Angela J.
    Ledger, Courtney
    Pratley, Richard
    [J]. OBESITY, 2011, 19 : S181 - S181
  • [38] The Role of Colesevelam HCl in Type 2 Diabetes Mellitus Therapy
    Handelsman, Yehuda
    [J]. POSTGRADUATE MEDICINE, 2009, 121 (03) : 19 - 24
  • [39] Empagliflozin as Add-On to Metformin for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Broedl, Uli C.
    Woerle, Hans J.
    [J]. DIABETES, 2013, 62 : A282 - A282
  • [40] Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
    Kovacs, Christopher S.
    Seshiah, Veeraswamy
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : 1773 - 1788
12345